Edge Wealth Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Edge Wealth Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-200	Closed	-$10K	–	652
2020 Q2	$10K	Buy	+200	New	+$15.4K	﹤0.01%	470
2020 Q1	–	Sell	-300	Closed	-$37K	–	694
2019 Q4	$37K	Buy	+300	New	+$26.9K	0.01%	280
2018 Q1	–	Sell	-750	Closed	-$44K	–	583
2017 Q4	$44K	Buy	750 +450	+150%	+$28.4K	0.01%	233
2017 Q3	$18K	Buy	+300	New	+$32.3K	0.01%	317
2015 Q1	–	Sell	-500	Closed	-$78K	–	488
2014 Q4	$78K	Buy	+500	New	+$92.4K	0.03%	165

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Edge Wealth Management's ICPT Position: Q3 2020 in Review

Edge Wealth Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 200 shares — an estimated $10K sold.

Edge Wealth Management first reported a position in ICPT in Q4 2014 and held it in 5 quarters. The position peaked at $78K in Q4 2014. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

Edge Wealth Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Edge Wealth Management sold 200 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10K.
Edge Wealth Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 5 quarters.
Edge Wealth Management's Intercept Pharmaceuticals, Inc. position peaked at $78K in Q4 2014.
177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Edge Wealth Management's 13F filing for Q3 2020, filed 21 Oct 2020.